Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans
Completed · Phase 1 · Has a placebo group
Conditions studied: Obesity
In brief
The overall hypothesis of this proposal is that nutrient sensing in the foregut regulates metabolic hormone secretion and nutrient metabolism via enteric neural signals, and these mechanisms might be defective in obesity.
Key facts
- Study ID
- NCT02537314
- Run by
- Vanderbilt University Medical Center
- People needed
- 27
- Starts
- 2015-09-01
- Expected to finish
- 2022-12-08
- Last updated by the study team
- 2026-06-11
Who can join
Age: 20 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- BMI 19 - 25 kg/m2 or 30 - 50 kg/m2
- Age 20 - 50 years
You may not qualify if…
- Contraindication to a nasoduodenal feeding tube (e.g., deviated nasal septum, prior upper gastrointestinal bleed, or history of easy bleeding)
- Prior gastric or intestinal surgery or pancreas resection
- Females with a positive pregnancy test
- Known history of intestinal diseases including, but not limited to, inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease), celiac sprue
- Type 1 or type 2 diabetes
- Recent presence of or treatment for gastroenteritis (diarrhea and/or vomiting), constipation, or upper respiratory infection
- Anemia
- Abnormal electrocardiogram
- Prior adverse reaction to anesthesia
- Tobacco use
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.